Related Experiment Video
Updated: Jan 16, 2026
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
Targeting the tumor microenvironment in pediatric gliomas: Advances and future directions in immunotherapy
Cheyenne Ahamed1, Lam Nguyen1, Cayley S Brock1
1Deparment of Neurosurgery, The University of Texas at Austin, Dell Medical School, Austin, TX, USA.
Abstract:
The tumor microenvironment (TME) is a critical determinant of tumor progression and therapeutic response in gliomas. While pediatric gliomas have historically been treated using strategies derived from the management of adult gliomas, emerging evidence reveals that pediatric gliomas possess a unique TME. The pediatric TME is distinct, characterized not only by differences in cellular composition but a lower mutational burden, diminished neoantigen presentation, and heightened immunosuppressive activity. The unique immune landscape, developmental trajectories, and immune escape mechanisms in the pediatric TME create barriers to effective therapy. Recent studies show promising results in novel and advanced therapeutic strategies, highlighting the potential for innovative immunotherapeutic approaches. Advances in methodologies for modeling the TME, including computational approaches and animal-based models, provide new insights into pediatric glioma biology. Utilization of computational models may provide opportunities to predict tumor response to specific therapies and tailor immunotherapy regimes to individuals, allowing for personalized care. Leveraging the unique features of the pediatric TME offers an opportunity to overcome current barriers to immunotherapy and develop more effective, age- and tumor-specific treatment strategies.
Insights
Pediatric gliomas have a unique tumor microenvironment (TME) distinct from adult tumors. Understanding these differences is key to developing effective immunotherapies for pediatric brain tumors.
Area of Science:
- Pediatric Oncology
- Immunology
- Computational Biology
Background:
- The tumor microenvironment (TME) significantly impacts glioma progression and treatment outcomes.
- Pediatric gliomas exhibit a TME distinct from adult gliomas, presenting unique therapeutic challenges.
Purpose of the Study:
- To highlight the unique characteristics of the pediatric tumor microenvironment in gliomas.
- To explore novel immunotherapeutic strategies tailored to the pediatric glioma TME.
- To discuss the role of advanced modeling techniques in understanding pediatric glioma biology.
Main Methods:
- Comparative analysis of pediatric and adult glioma TME cellular composition and immune landscape.
- Review of recent advancements in pediatric glioma immunotherapy.
- Exploration of computational and animal models for TME research.
Main Results:
- The pediatric TME is characterized by lower mutational burden, reduced neoantigen presentation, and increased immunosuppression.
- Unique immune landscapes and developmental trajectories create barriers to effective therapy in pediatric gliomas.
- Novel therapeutic strategies show promise for overcoming these barriers.
Conclusions:
- The distinct pediatric TME necessitates the development of age- and tumor-specific treatment strategies.
- Computational models offer potential for predicting treatment response and personalizing immunotherapy.
- Leveraging unique pediatric TME features can enhance immunotherapy efficacy for pediatric gliomas.
